Scott Chasan-Taber

5.4k citations

25 papers · 4.3k indexed · 3 hit papers · h-index 19

Impact in

Nephrology top 0.2%
- Parathyroid Disorders and Treatments
- Dialysis and Renal Disease Management
Nutrition and Dietetics top 1%
- Magnesium in Health and Disease

Papers in

Nephrology 9
- Parathyroid Disorders and Treatments 8
Applied Psychology 2

Co-authors: Steven K. Burke Glenn M. Chertow Paolo Raggi Maureen Dillon Naseem Amin Arnold M. Epstein Joel S. Weissman John Z. Ayanian
Journals: Medical Care (3 papers)Journal of clinical lipidology (2 papers)Nephrology Dialysis Transplantation (2 papers)Journal of the American College of Cardiology (2 papers)American Journal of Kidney Diseases (2 papers)
Partner nations: United States Germany United Kingdom

In The Last Decade

Scott Chasan-Taber

24 papers receiving 4.2k citations

Hit Papers

align trajectories log scale

Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials 2014 · 394 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2014 Clinical Infectious Diseases
2010 The Lancet
2002 Journal of the American College of Cardiology

Peers

Countries citing papers authored by Scott Chasan-Taber

Since Specialization

Citations

This map shows the geographic impact of Scott Chasan-Taber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Chasan-Taber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Chasan-Taber more than expected).

Fields of papers citing papers by Scott Chasan-Taber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Chasan-Taber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Chasan-Taber. The network helps show where Scott Chasan-Taber may publish in the future.

Co-authors

The 25 scholars most cited alongside Scott Chasan-Taber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Scott Chasan-Taber Line = papers co-authored together Scott Chasan-Taber links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials Clinical Infectious Diseases ·Stuart Johnson, Thomas Louie, Dale N. Gerding, Oliver A. Cornely, Scott Chasan-Taber, David Fitts, Steven P Gelone, Colin Broom, David M. Davidson, (unknown) Hit paper breakdown →	2014	394
2	Randomized, Placebo-Controlled Trial of Mipomersen in Patients with Severe Hypercholesterolemia Receiving Maximally Tolerated Lipid-Lowering Therapy PLoS ONE ·Mary P. McGowan, Jean‐Claude Tardif, R Češka, Lesley Burgess, Handrean Soran, Ioanna Gouni‐Berthold, Gilbert Wagener, Scott Chasan-Taber	2012	176
3	APOLIPOPROTEIN B SYNTHESIS INHIBITION BY MIPOMERSEN REDUCES LOW-DENSITY LIPOPROTEIN CHOLESTEROL WHEN ADDED TO MAXIMALLY TOLERATED LIPID-LOWERING MEDICATION IN PATIENTS WITH SEVERE HETEROZYGOUS HYPERCHOLESTEROLEMIA Journal of the American College of Cardiology ·Jean‐Claude Tardif, Mary P. McGowan, R Češka, Lesley Burgess, Handrean Soran, Ioanna Gouni‐Berthold, Gilbert Wagener, Scott Chasan-Taber	2011	14
4	Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial The Lancet ·Frederick J. Raal, Raúl D. Santos, Dirk Blom, A. David Marais, Min‐Ji Charng, William C. Cromwell, Robin Lachmann, Daniel Gaudet, Ju Le Tan, Scott Chasan-Taber, Diane L. Tribble, JoAnn Flaim, Stanley T. Crooke Hit paper breakdown →	2010	692
5	P431 MIPOMERSEN, AN apo B SYNTHESIS INHIBITOR, PREFERENTIALLY REDUCES SMALL LDL PARTICLE NUMBER AND INCREASES LDL PARTICLE SIZE IN HoFH PATIENTS Atherosclerosis Supplements ·William C. Cromwell, Luciano H. Tamargo, Dirk Blom, A. David Marais, Min‐Ji Charng, Robin Lachmann, Daniel Gaudet, Ju Le Tan, Diane L. Tribble, JoAnn Flaim, Scott Chasan-Taber, Zhuangzhuang Tian, Frederick J. Raal	2010	3
6	A Randomized, Parallel, Open-Label Study to Compare Once-Daily Sevelamer Carbonate Powder Dosing With Thrice-Daily Sevelamer Hydrochloride Tablet Dosing in CKD Patients on Hemodialysis American Journal of Kidney Diseases ·Steven Fishbane, James A. Delmez, Wadi N. Suki, Kay-Chuan Benny Tan, Jeremy P.W. Heaton, Scott Chasan-Taber, Melissa A. Plone, Sharon M. Moe	2009	22
7	Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis Nephrology Dialysis Transplantation ·Pieter Evenepoel, Rafael Selgas, (unknown), Lukas Foggensteiner, James Heaf, Alberto Ortíz, Alison Kelly, Scott Chasan-Taber, Ajay Duggal, Stanley Fan	2008	59
8	Efficacy and Tolerability of Sevelamer Carbonate in Hyperphosphatemic Patients Who Have Chronic Kidney Disease and Are Not on Dialysis Clinical Journal of the American Society of Nephrology ·Markus Ketteler, Marianne Rix, Stanley Fan, Bachtiar Yusuf Habibi, Deping Ye, Scott Chasan-Taber, Jeremy P.W. Heaton, Ajay Duggal, Philip A. Kalra	2008	66
9	A randomized, double-blind, crossover design study of sevelamer hydrochloride and sevelamer carbonate in patients on hemodialysis Clinical Nephrology ·James A. Delmez, Gilbert Block, John A. Robertson, Scott Chasan-Taber, Andrew T. Blair, Maureen Dillon, Anthony J. Bleyer	2007	74
10	Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients Kidney International ·Wadi N. Suki, Raja I. Zabaneh, José L. Cangiano, John Reed, D Fischer, Leland E. Garrett, Dina Mahmuda, Scott Chasan-Taber, Maureen Dillon, Andrew T. Blair, Steven K. Burke	2007	363
11	Determinants of progressive vascular calcification in haemodialysis patients Nephrology Dialysis Transplantation ·Glenn M. Chertow, Paolo Raggi, Scott Chasan-Taber, J. Bommer, H. Hölzer, Steven K. Burke	2004	231
12	Cardiac calcification in adult hemodialysis patients Journal of the American College of Cardiology ·Paolo Raggi, Huan Ding, Scott Chasan-Taber, Naseem Amin, Maureen Dillon, Steven K. Burke, Glenn M. Chertow Hit paper breakdown →	2002	922
13	Validity and reproducibility of a physical activity questionnaire in women Medicine & Science in Sports & Exercise ·Lisa Chasan‐Taber, J. Bianca Erickson, Philip C. Nasca, Scott Chasan-Taber, Patty S. Freedson	2002	58
14	Quality of Care by Race and Gender for Congestive Heart Failure and Pneumonia Medical Care ·John Z. Ayanian, Joel S. Weissman, Scott Chasan-Taber, Arnold M. Epstein	1999	177
15	Hospital Readmissions and Quality of Care Medical Care ·Joel S. Weissman, John Z. Ayanian, Scott Chasan-Taber, Marjorie J. Sherwood, Carol P. Roth, Arnold M. Epstein	1999	105
16	Reproducibility and validity of a self-administered physical activity questionnaire for male health professionals. Rehabilitation Oncology ·Scott Chasan-Taber, EB Rimm, MJ Stampfer, D Spiegelman, Graham A. Colditz, Edward L. Giovannucci, Alberto Ascherio, WC Willett	1998	0
17	Treatment of rheumatoid arthritis with oral type II collagen: Results of a multicenter, double-blind, placebo-controlled trial Arthritis & Rheumatism ·Sedanur Savas, Joel M. Kremer, E. William St. Clair, Daniel O. Clegg, Daniel E. Furst, Michael H. Weisman, Malcolm Fletcher, Scott Chasan-Taber, Eduardo Finger, Alejandro Morales, Christine Le, David E. Trentham	1998	177
18	Quality Of Care For Two Common Illnesses In Teaching And Nonteaching Hospitals Health Affairs ·John Z. Ayanian, Joel S. Weissman, Scott Chasan-Taber, Arnold M. Epstein	1998	85
19	The Influence of Health-Related Quality of Life and Social Characteristics on Hospital Use by Patients with AIDS in the Boston Health Study Medical Care ·Joel S. Weissman, Paul D. Cleary, George R. Seage, Constantine Gatsonis, Jennifer S. Haas, Scott Chasan-Taber, Arnold M. Epstein	1996	22
20	Reproducibility and Validity of a Self-Administered Physical Activity Questionnaire for Male Health Professionals Epidemiology ·Scott Chasan-Taber, Eric B. Rimm, Meir J. Stampfer, Donna Spiegelman, Graham A. Colditz, Edward Giovannucci, Alberto Ascherio, W. C. Willett	1996	451

About Scott Chasan-Taber

Scott Chasan-Taber is a scholar working on Nephrology, Applied Psychology, Endocrinology, Diabetes and Metabolism, Nutrition and Dietetics and Cancer Research, having authored 25 papers that have together received 4.3k indexed citations. Recurring topics across this work include Parathyroid Disorders and Treatments (8 papers), Lipoproteins and Cardiovascular Health (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Magnesium in Health and Disease (5 papers), Cancer, Lipids, and Metabolism (4 papers), Healthcare Policy and Management (3 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Vitamin D Research Studies (2 papers). The work is most often cited by research in Nephrology (1.7k citations), Nutrition and Dietetics (731 citations), Cardiology and Cardiovascular Medicine (596 citations), Surgery (1.1k citations) and Pathology and Forensic Medicine (434 citations). Scott Chasan-Taber has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Steven K. Burke, Glenn M. Chertow, Paolo Raggi, Maureen Dillon, Naseem Amin, Arnold M. Epstein, Joel S. Weissman, John Z. Ayanian, Eric B. Rimm and Alberto Ascherio. Their work appears in journals such as Medical Care, Journal of clinical lipidology, Nephrology Dialysis Transplantation, Journal of the American College of Cardiology and American Journal of Kidney Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact